drugset / Trial / NCT01244971
Exercise and Acarbose in Type 2 Diabetes
Phase 4
Completed
62 enrolled
Karolinska Institutet
Bayer · collabThe Swedish Research Council · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the impact of exercise training, Acarbose, and the combination of exercise and Acarbose on glycemic control, body composition, insulin sensitivity and other cardiovascular risk markers in type 2 diabetes. Further, muscle biopsies will be obtain to study gene expression. Our hypothesis is that the combination therapy will be superior to monotherapy with exercise or Acarbose.
Timeline
- Start
- 2004-01
- Primary completion
- 2004-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acarbose | Unknown | 100 mg | — |